Komen's Executive Resigns Amid Funding Controversy [FULL TEXT]

An executive at Susan G. Komen for the Cure, a breast cancer organization, will resign from the foundation a week after the group's to controversial decision to pull funding from Planned Parenthood.

Karen Handel, vice president of public policy and an former Republican politician, posted a letter of resignation on her personal website Tuesday, going out swinging against the gross mischaracterizations of a change in the foundation's grant strategy that would have cut grants to Planned Parenthood.

I am deeply disappointed by the gross mischaracterizations of the strategy, its rationale, and my involvement in it, she wrote. I openly acknowledge my role in the matter and continue to believe our decision was the best one for Komen's future and the women we serve.

The funding Komen provided to Planned Parenthood covered breast cancer screenings. The organization instituted a new funding policy that would cut off groups under federal or local investigations; Planned Parenthood is currently being probed by Rep. Cliff Stearns, a Republican from Florida. Stearns, who is anti-choice, is looking into whether federal funding illegally goes to the health organization's abortion services.

With Planned Parenthood constantly in the cross-hairs of Republicans who now control the House of Representatives, supporters of the women's health organization saw political motives in the investigation and Komen's decision to cut funding to its clinics. Komen's co-founder and CEO, Nancy Brinker, an ambassador in the second Bush Administration, apologized for the funding decision and altered the group's grant criteria to cover only criminal investigations that are conclusive.

Before joining Komen, Handel, who said she is declining a severance package, served as Georgia's secretary of state and lost the GOP primary during her run for governor in 2010.

Here is the text of her resignation letter.

February 7, 2012

The Honorable Nancy Brinker

CEO, Susan G. Komen for the Cure VIA EMAIL

5005 LBJ Freeway, Suite 250

Dallas, Texas 75244

Dear Ambassador Brinker:

Susan G. Komen for the Cure has been the recognized leader for more 30 years in the fight against breast cancer here in the US - and increasingly around the world.

As you know, I have always kept Komen's mission and the women we serve as my highest priority - as they have been for the entire organization, the Komen Affiliates, our many supporters and donors, and the entire community of breast cancer survivors. I have carried out my responsibilities faithfully and in line with the Board's objectives and the direction provided by you and Liz.

We can all agree that this is a challenging and deeply unsettling situation for all involved in the fight against breast cancer. However, Komen's decision to change its granting strategy and exit the controversy surrounding Planned Parenthood and its grants was fully vetted by every appropriate level within the organization. At the November Board meeting, the Board received a detailed review of the new model and related criteria. As you will recall, the Board specifically discussed various issues, including the need to protect our mission by ensuring we were not distracted or negatively affected by any other organization's real or perceived challenges. No objections were made to moving forward.

I am deeply disappointed by the gross mischaracterizations of the strategy, its rationale, and my involvement in it. I openly acknowledge my role in the matter and continue to believe our decision was the best one for Komen's future and the women we serve. However, the decision to update our granting model was made before I joined Komen, and the controversy related to Planned Parenthood has long been a concern to the organization. Neither the decision nor the changes themselves were based on anyone's political beliefs or ideology. Rather, both were based on Komen's mission and how to better serve women, as well as a realization of the need to distance Komen from controversy. I believe that Komen, like any other nonprofit organization, has the right and the responsibility to set criteria and highest standards for how and to whom it grants.

What was a thoughtful and thoroughly reviewed decision - one that would have indeed enabled Komen to deliver even greater community impact - has unfortunately been turned into something about politics. This is entirely untrue. This development should sadden us all greatly.

Just as Komen's best interests and the fight against breast cancer have always been foremost in every aspect of my work, so too are these my priorities in coming to the decision to resign effective immediately. While I appreciate your raising a possible severance package, I respectfully decline. It is my most sincere hope that Komen is allowed to now refocus its attention and energies on its mission.

--